Program Code: SCF-DBI-PCICU-PH-0001**
Operational Window: Initial Diagnosis → Acute Stabilization → Rescue Phase → Recovery Phase → Longitudinal Surveillance
Primary Objective: Preserve pulmonary vascular adaptation, prevent right ventricular collapse, maintain systemic oxygen delivery, protect neurodevelopment, and optimize long-term cardiopulmonary resilience.
SECTION 10.1
CLINICAL POSITIONING
Traditional Pulmonary Hypertension Model
Focuses on:
Pulmonary artery pressures
Right ventricular function
Oxygenation
Vasodilator therapy
Survival
SCF-DBI Pulmonary Hypertension Model
Pulmonary hypertension is viewed as:
Pulmonary Vascular Intelligence Failure Syndrome
affecting:
Right ventricular adaptation
Endothelial intelligence
Cerebral oxygen delivery
Growth biology
Recovery intelligence
Core Principle
The disease is not merely elevated pulmonary pressure.
The disease is progressive loss of pulmonary-cardiovascular adaptation.
SECTION 10.2
PULMONARY VASCULAR INTELLIGENCE MODEL
Domain 1
Pulmonary Vascular Adaptation
Maintains:
Pulmonary blood flow
Pulmonary vascular compliance
Oxygen exchange
Domain 2
Right Ventricular Adaptation
Maintains:
RV output
RV reserve
Coronary perfusion
Domain 3
Systemic Adaptation
Maintains:
Organ perfusion
Oxygen delivery
Recovery reserve
Domain 4
Developmental Adaptation
Maintains:
Growth
Neurodevelopment
Functional progression
Primary Output
Pulmonary Vascular Intelligence Score (PVIS)
SECTION 10.3
PULMONARY HYPERTENSION CLASSIFICATION
Group I
Pulmonary Arterial Hypertension
Group II
Pulmonary Venous Hypertension
Group III
Pulmonary Disease-Associated Hypertension
Group IV
Chronic Thromboembolic Disease
Group V
Multifactorial Pulmonary Hypertension
SCF Classification
Adaptive
Threatened
Failing
Collapsing
SECTION 10.4
RIGHT VENTRICULAR FAILURE FRAMEWORK
Clinical Positioning
RV failure represents:
Pulmonary-Cardiac Adaptation Failure
Pathophysiology
Elevated Pulmonary Resistance
↓
RV Pressure Overload
↓
Reduced RV Output
↓
Reduced LV Filling
↓
Reduced Systemic Output
↓
Multi-System Adaptation Failure
Core Threats
Systemic hypoperfusion
Coronary insufficiency
Cerebral hypoxia
Recovery disruption
SECTION 10.5
RIGHT VENTRICULAR FAILURE SURVEILLANCE
Hemodynamic Monitoring
RV function
RV size
Pulmonary pressures
Cardiac output
Perfusion Monitoring
Lactate
Mixed venous oxygen saturation
NIRS
Urine output
SCF Monitoring
PVIS
ANMS
NCRS
EII
CAI
SECTION 10.6
PULMONARY HYPERTENSIVE CRISIS SOP
Clinical Positioning
Pulmonary hypertensive crisis represents:
Acute Pulmonary Vascular Intelligence Collapse
Immediate Threats
RV failure
Severe hypoxemia
Cardiogenic shock
Cardiac arrest
Early Warning Indicators
Rising pulmonary pressures
RV dysfunction
Falling NIRS
Lactate elevation
NCRS decline
Crisis Classification
Stage I
Threatened
Stage II
Progressive
Stage III
Severe
Stage IV
Critical
SECTION 10.7
RHENOVA PULMONARY-CARDIAC PRESERVATION BUNDLE
Strategic Objective
Interrupt pulmonary-cardiac collapse before irreversible injury occurs.
Bundle Components
Component 1
Pulmonary Adaptation Preservation
Component 2
RV Preservation
Component 3
Neuroprotection
Component 4
Endothelial Protection
Component 5
Recovery Preservation
Monitoring
PVIS
ANMS
EII
CAI
NCRS
SECTION 10.8
ENDOTHELIAL INTELLIGENCE IN PULMONARY HYPERTENSION
Clinical Positioning
Endothelial dysfunction is a central driver of disease progression.
Monitoring Domains
Vascular adaptation
Microvascular integrity
Oxygen delivery
Pulmonary circulation resilience
Output
Endothelial Intelligence Index (EII)
Escalation Indicators
EII decline >15%
Increasing oxygen requirement
Progressive RV dysfunction
SECTION 10.9
PULMONARY VASCULAR RECOVERY PLATFORM
Strategic Objective
Preserve and restore pulmonary vascular adaptation.
Recovery Domains
RV recovery
Endothelial recovery
Neurodevelopmental recovery
Functional recovery
Exercise recovery
Recovery Monitoring
PVIS
EII
NCRS
Recovery Readiness Index
SECTION 10.10
CARDIOPULMONARY INTERACTION FRAMEWORK
Purpose
Monitor dynamic interaction between:
Pulmonary circulation
RV performance
Systemic circulation
Cerebral perfusion
Surveillance Variables
Echocardiography
Pulmonary pressures
NIRS
Lactate
PVIS
SECTION 10.11
ECMO CONSIDERATION FRAMEWORK
Clinical Positioning
ECMO serves as:
Pulmonary-Cardiac Recovery Preservation Technology
Consideration Criteria
Refractory pulmonary hypertensive crisis
Progressive RV failure
Severe hypoxemia
Progressive ANMS decline
ECMO Objectives
Restore oxygen delivery
Preserve cerebral adaptation
Preserve RV recovery potential
SECTION 10.12
PULMONARY HYPERTENSION ANMS FRAMEWORK
Neuroimmune Domain
Monitor:
Inflammatory burden
Recovery burden
Neurocardiac Domain
Monitor:
RV adaptation
Systemic output
Neurovascular Domain
Monitor:
EII
Pulmonary vascular adaptation
Neurometabolic Domain
Monitor:
Oxygen utilization
Lactate
Neuroendocrine Domain
Monitor:
Stress burden
Recovery reserve
SECTION 10.13
ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
PVIS decline >10%
Increased oxygen requirement
Level 2
Focused Intervention
Triggers:
RV dysfunction progression
EII decline >15%
Level 3
Multidisciplinary Escalation
Triggers:
Pulmonary hypertensive crisis
NCRS decline >20%
Level 4
Advanced Rescue Activation
Triggers:
Severe RV failure
Progressive shock
Level 5
ECMO Rescue Consideration
Triggers:
ANMS <40
Refractory crisis
Imminent circulatory collapse
SECTION 10.14
LONGITUDINAL PULMONARY HYPERTENSION SURVEILLANCE
Follow-Up Timeline
ICU Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
↓
Annual Surveillance
Surveillance Domains
Pulmonary vascular adaptation
RV function
Neurodevelopment
Exercise capacity
Growth
SECTION 10.15
PULMONARY HYPERTENSION SUCCESS ENDPOINTS
Clinical
Stable pulmonary hemodynamics
Preserved RV function
Reduced hospitalization
Functional
Improved exercise tolerance
Age-appropriate development
Educational participation
Biological Intelligence
ANMS >80
PVIS >80
NCRS >80
EII >80
CAI >80
Sustained adaptive stability
PAGE 10 COMPLETION
Next Page (Page 11):